Perioperative Use of Inhaled and Intravenous Iloprost in Patients with Pulmonary Hypertension during Non-cardiac Surgery

Iloprost in Patients with Pulmonary Hypertension during Non-cardiac Surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-12002826

Enrollment

Unknown

Registered

2012-12-21

Start date

2008-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Pulmonary Hypertension

Interventions

treatment group:Iloprost Inhalation

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Severe pulmonary hypertension patients undergoning selective non-cardiac operation; (2) mPAP>25mmHg, PCWP3 wood unit; (3) excluded pulmonary arterial hypertension secondary to pulmonary diseases; (4) 6MWD between 150m and 450m; (5) WHO pulmonary hypertension functional Class II - III; (6) acquired informed consent.

Exclusion criteria

Exclusion criteria: (1) denied informed consent and no cooperative patients; (2) with sever hepatic, renal and central nervous system diseases; (3) with unstable angina or myocardial infarction, stoke, and fatal arrhythemia within 6 months.

Design outcomes

Primary

Measure	Time frame
pulmonary hemodynamic indeces;	—

Countries

China

Contacts

Public ContactLei Pan

leipan61@yahoo.com.cn+86 10 63926750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026